China Feihe Limited (CHFLF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
China Feihe Limited (CHFLF) with AI Score 52/100 (Hold). China Feihe Limited is a leading infant milk formula producer in China. The company also offers a range of raw milk, adult milk powders, liquid milk products, and health care products. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 15, 2026China Feihe Limited (CHFLF) Consumer Business Overview
China Feihe Limited is a prominent infant milk formula producer in Mainland China and the United States, offering diverse dairy and nutritional products via distributors and e-commerce platforms. With a strong distribution network and focus on infant nutrition, the company maintains a significant presence in the competitive packaged foods sector.
Investment Thesis
China Feihe Limited presents a compelling investment case based on its established market position and growth opportunities in the infant milk formula sector. With a P/E ratio of 11.47 and a profit margin of 13.6%, the company demonstrates solid profitability. A dividend yield of 7.36% offers an attractive income stream for investors. Growth catalysts include expanding its product line and further penetration into e-commerce channels. However, investors may want to evaluate risks such as intense competition and changing consumer preferences. The company's beta of 0.56 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $3.96 billion reflects China Feihe's significant presence in the infant milk formula market.
- P/E ratio of 11.47 indicates a potentially undervalued stock compared to industry peers.
- Profit margin of 13.6% demonstrates the company's ability to generate profits from its sales.
- Gross margin of 63.4% highlights efficient production and pricing strategies.
- Dividend yield of 7.36% provides an attractive income stream for investors.
Competitors & Peers
Strengths
- Strong brand reputation in China.
- Extensive distribution network.
- Diversified product portfolio.
- High gross margin.
Weaknesses
- Reliance on the Chinese market.
- Exposure to regulatory risks in China.
- Limited presence in international markets.
- Dependence on distributors.
Catalysts
- Ongoing: Expansion of e-commerce sales channels to reach a wider customer base.
- Ongoing: Development and launch of new and innovative infant milk formula products.
- Upcoming: Potential acquisitions of smaller competitors to expand market share.
- Ongoing: Increasing brand awareness and marketing efforts to drive sales.
- Ongoing: Strategic partnerships with distributors to enhance market reach.
Risks
- Ongoing: Intense competition from domestic and international players in the infant milk formula market.
- Potential: Changing consumer preferences and demand for alternative products.
- Ongoing: Food safety concerns and potential product recalls.
- Potential: Economic slowdown in China impacting consumer spending.
- Ongoing: Regulatory risks and changes in government policies.
Growth Opportunities
- Expanding Product Line: China Feihe can capitalize on the growing demand for specialized infant milk formulas, such as organic or hypoallergenic options. The global infant formula market is projected to reach $55 billion by 2028, offering significant growth potential. By investing in research and development, China Feihe can introduce innovative products that cater to specific dietary needs and preferences, strengthening its competitive edge.
- E-commerce Penetration: The increasing adoption of online shopping in China presents a major growth opportunity for China Feihe. E-commerce platforms like Tmall and JD.com offer a direct channel to reach consumers and expand market reach. By enhancing its online presence and optimizing its e-commerce strategies, China Feihe can tap into the growing online retail market, which is expected to reach $3.3 trillion in China by 2025.
- Geographic Expansion: While China Feihe already has a presence in the United States, further geographic expansion into other international markets can drive growth. Emerging markets in Asia and Africa offer significant potential due to rising birth rates and increasing disposable incomes. By establishing strategic partnerships and adapting its products to local preferences, China Feihe can successfully penetrate new markets and diversify its revenue streams.
- Strategic Acquisitions: China Feihe can pursue strategic acquisitions to expand its product portfolio and market share. Acquiring smaller competitors or companies with complementary product lines can provide access to new technologies, distribution networks, and customer bases. This strategy can accelerate growth and strengthen China Feihe's position in the competitive infant milk formula market.
- Premiumization Strategy: As consumer incomes rise, there is a growing demand for premium infant milk formula products. China Feihe can capitalize on this trend by focusing on developing and marketing high-end products with superior ingredients and nutritional benefits. By emphasizing product quality and brand image, China Feihe can attract affluent consumers and increase its profit margins.
Opportunities
- Expanding into new geographic markets.
- Developing new and innovative products.
- Increasing e-commerce sales.
- Acquiring smaller competitors.
Threats
- Intense competition from domestic and international players.
- Changing consumer preferences.
- Food safety concerns.
- Economic slowdown in China.
Competitive Advantages
- Strong brand recognition in the Chinese infant milk formula market.
- Extensive distribution network with a large number of retail points of sale.
- Diversified product portfolio catering to different consumer segments.
- Established relationships with distributors and e-commerce platforms.
About CHFLF
Founded in 1962 and headquartered in Beijing, China Feihe Limited has grown to become a significant player in the infant milk formula market. The company's core business revolves around the production and sale of infant milk formula products, primarily in Mainland China and the United States. Over the years, China Feihe has expanded its product portfolio to include a variety of dairy and nutritional products, such as raw milk, adult milk powders, liquid milk products, health care products, soybean powder, and goat milk powder. These products cater to different consumer segments, from infants to adults, reflecting the company's diversified approach to the dairy market. China Feihe distributes its products through an extensive network of distributors, as well as through e-commerce platforms like Tmall, JD.com, and Suning.com. The company also leverages its own website, mobile application, and WeChat platform to reach consumers directly. As of December 31, 2021, China Feihe operated a distribution network of approximately 2,000 offline customers with 110,000 retail points of sale, highlighting its extensive market reach. The company's commitment to quality and innovation has solidified its position in the competitive packaged foods industry.
What They Do
- Produces and sells infant milk formula products.
- Offers raw milk, adult milk powders, and liquid milk products.
- Provides health care products and nutritional supplements.
- Sells soybean powder and goat milk powder.
- Operates through distributors and e-commerce platforms.
- Maintains a distribution network of approximately 2,000 offline customers.
Business Model
- Manufactures a range of dairy and nutritional products.
- Distributes products through offline and online channels.
- Generates revenue through sales of infant milk formula and related products.
- Focuses on brand building and marketing to drive sales.
Industry Context
China Feihe Limited operates in the competitive packaged foods industry, specifically focusing on the infant milk formula market. This sector is characterized by evolving consumer preferences, stringent quality standards, and intense competition from both domestic and international players. The industry is influenced by factors such as population growth, urbanization, and increasing disposable incomes, particularly in developing markets. China Feihe's strong distribution network and brand recognition position it favorably within this landscape, but it must continually innovate and adapt to maintain its market share against competitors like Associated Co. of Pakistan (ACOPF) and Nestle (NCHEY).
Key Customers
- Infants and young children requiring milk formula.
- Adults consuming milk powders and liquid milk products.
- Consumers seeking health care products and nutritional supplements.
- Distributors and retailers selling China Feihe products.
- Online shoppers purchasing products through e-commerce platforms.
Financials
Chart & Info
China Feihe Limited (CHFLF) stock price: Price data unavailable
Latest News
No recent news available for CHFLF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHFLF.
Price Targets
Wall Street price target analysis for CHFLF.
MoonshotScore
What does this score mean?
The MoonshotScore rates CHFLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Youbin Leng
CEO
Youbin Leng is the CEO of China Feihe Limited, leading a workforce of 9590 employees. His background includes extensive experience in the dairy industry, with a focus on strategic planning and operational management. He has been instrumental in driving the company's growth and expansion in the Chinese market. Leng's leadership is characterized by a commitment to quality, innovation, and customer satisfaction.
Track Record: Under Youbin Leng's leadership, China Feihe has achieved significant milestones, including expanding its product portfolio and strengthening its distribution network. He has overseen the company's growth in the e-commerce sector and has implemented strategies to enhance brand recognition. Leng's focus on quality control and food safety has been crucial in maintaining consumer trust and confidence in China Feihe's products.
CHFLF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that China Feihe Limited may not meet the minimum financial standards required for listing on major exchanges like the NYSE or NASDAQ. Companies on this tier may have limited reporting requirements and may not be subject to the same level of regulatory scrutiny as those listed on higher-tier exchanges. This can result in increased risks for investors due to the potential for less transparency and liquidity compared to listed companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Lower liquidity and trading volume.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal standing.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Established history of operations since 1962.
- Significant market capitalization of $3.96 billion.
- Presence in the infant milk formula market.
- Extensive distribution network with retail points of sale.
- Availability of products through e-commerce platforms.
What Investors Ask About China Feihe Limited (CHFLF)
What does China Feihe Limited do?
China Feihe Limited is a leading producer of infant milk formula products, primarily operating in Mainland China and the United States. The company offers a comprehensive range of dairy and nutritional products, including raw milk, adult milk powders, liquid milk products, health care products, soybean powder, and goat milk powder. These products are distributed through an extensive network of offline customers and e-commerce platforms, such as Tmall and JD.com, as well as through the company's own website and mobile application. China Feihe focuses on providing high-quality products to meet the nutritional needs of infants and adults.
What do analysts say about CHFLF stock?
AI analysis is pending for CHFLF stock. However, based on available financial data, China Feihe Limited has a market capitalization of $3.96 billion and a P/E ratio of 11.47. The company's profit margin is 13.6%, and its gross margin is 63.4%. The stock has a beta of 0.56 and a dividend yield of 7.36%. These metrics suggest a potentially undervalued stock with a stable financial performance. Investors should conduct their own research and consider the risks associated with investing in OTC stocks before making any investment decisions.
What are the main risks for CHFLF?
China Feihe Limited faces several risks, including intense competition from domestic and international players in the infant milk formula market. Changing consumer preferences and demand for alternative products, such as organic or plant-based formulas, could impact sales. Food safety concerns and potential product recalls pose a significant risk to the company's reputation and financial performance. An economic slowdown in China could reduce consumer spending on infant milk formula products. Regulatory risks and changes in government policies related to the dairy industry could also affect China Feihe's operations.
What are the key factors to evaluate for CHFLF?
China Feihe Limited (CHFLF) currently holds an AI score of 52/100, indicating moderate score. Key strength: Strong brand reputation in China.. Primary risk to monitor: Ongoing: Intense competition from domestic and international players in the infant milk formula market.. This is not financial advice.
How frequently does CHFLF data refresh on this page?
CHFLF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CHFLF's recent stock price performance?
Recent price movement in China Feihe Limited (CHFLF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong brand reputation in China.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CHFLF overvalued or undervalued right now?
Determining whether China Feihe Limited (CHFLF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CHFLF?
Before investing in China Feihe Limited (CHFLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC market data may be less reliable than major exchange data.
- AI analysis is pending and may provide further insights.